Challenges with technical transferability, data consistency, and product performance predictability across different drug development stages can lead to unnecessary delays and escalating costs. This technical article presents a harmonized and streamlined approach established at Thermo Fisher Scientific for manufacturing AAV and LV vectors for discovery research using technologies and processes mirroring current GMP platforms.